You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 6, June 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (59)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Staging of Breast Cancer

A New Rationale for Internal Mammary Node Biopsy

Monica Morrow, MD; Roger S. Foster, Jr, MD

Arch Surg. 1981;116(6):748-751.


Abstract

• Metastases to the axillary nodes, the internal mammary nodes, or both, define a group of patients at very high risk of having systemic micrometastases leading to recurrent disease and death if surgical therapy alone is used. In our review of 7,070 patients with breast cancer in whom both axillary nodes and internal mammary nodes were examined histologically, 5% to 10% had internal mammary node metastases in the absence of axillary node metastases. With the availability of effective systemic therapy that can improve the survival of patients with operable breast cancer who have lymph node metastases, information obtained from internal mammary node biopsies assumes practical significance. Our current policy is to perform internal mammary node biopsies on patients with operable breast cancer who have medial and central primary tumors of any size and lateral primary tumors 2 cm or greater in diameter if a frozen section of the most suspicious node in the axillary dissection shows no histologic evidence of metastasis.

(Arch Surg 1981;116:748-751)



Author Affiliations

From the Department of Surgery, University of Vermont College of Medicine, Burlington.


Footnotes

Accepted for publication Jan 29, 1981.

Reprint requests to Department of Surgery, Given Building, University of Vermont College of Medicine, Burlington, VT 05405 (Dr Foster).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sentinel Lymph Node Detection in Patients with Early-Stage Breast Cancer: Comparison of Periareolar and Subdermal/Peritumoral Injection Techniques
Pelosi et al.
JNM 2004;45:220-225.
ABSTRACT | FULL TEXT  

Diminished Survival in Patients With Inner Versus Outer Quadrant Breast Cancers
Gaffney et al.
JCO 2003;21:467-472.
ABSTRACT | FULL TEXT  

Breast Cancer: Variables Affecting Sentinel Lymph Node Visualization at Preoperative Lymphoscintigraphy
Birdwell et al.
Radiology 2001;220:47-53.
ABSTRACT | FULL TEXT  

Alternative Strategies in the Management of Primary Breast Cancer
Foster and Wood
Arch Surg 1998;133:1182-1186.
ABSTRACT | FULL TEXT  

The Sentinel Node in Breast Cancer -- A Multicenter Validation Study
Krag et al.
NEJM 1998;339:941-946.
ABSTRACT | FULL TEXT  

Internal Mammary Nodal Status Is a More Reliable Prognostic Factor Than DNA Ploidy and c-erb B-2 Expression in Patients With Breast Cancer
Noguchi et al.
Arch Surg 1993;128:242-246.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.